These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29423397)

  • 1. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
    Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
    Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
    Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
    J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies.
    Nath SC; Menendez L; Friedrich Ben-Nun I
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
    Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
    JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
    Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
    Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generating pluripotent stem cells: differential epigenetic changes during cellular reprogramming.
    Tobin SC; Kim K
    FEBS Lett; 2012 Aug; 586(18):2874-81. PubMed ID: 22819821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprint of "iPSCs, aging and age-related diseases".
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells in companion animals: how can we move the field forward?
    Barrachina L; Arshaghi TE; O'Brien A; Ivanovska A; Barry F
    Front Vet Sci; 2023; 10():1176772. PubMed ID: 37180067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
    Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
    Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source cell-type epigenetic memory persists in induced pluripotent cells but is lost in subsequently derived germline cells.
    Lin YH; Lehle JD; McCarrey JR
    Front Cell Dev Biol; 2024; 12():1306530. PubMed ID: 38410371
    [No Abstract]   [Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.